ChinaDaily Briefs

Daily Brief China: Alibaba (ADR), J&T Global Express, Shiyue Daotian, Yankuang Energy Group, Mobvoi, Viva Biotech Holdings and more

In today’s briefing:

  • Alibaba (BABA US): Watch Headlines and Stay Grounded in Numbers
  • J&T Global Express Pre-IPO Tearsheet
  • J&T Global Express IPO: The Bull Case
  • Shiyue Daotian (十月稻田) Pre-IPO: Aggressive Brands – A Local Viewpoint
  • Morning Views Asia: Yankuang Energy Group
  • Mobvoi IPO: Rapidly Growing AI Unicorn And Creator of Universal LLM “Xuliehouzi.”
  • Viva Biotech Holdings (1873.HK) – The Restructuring Plan Would Not Turn Things Around


Alibaba (BABA US): Watch Headlines and Stay Grounded in Numbers

By Eric Chen

  • We expect June quarter results to beat consensus and demonstrate a balanced growth across topline and bottom-line.
  • During a time when headlines drive BABA share price, it is more important to stay grounded in numbers, see what is in price and make trades accordingly.
  • We maintain US$500 billion target market cap on 20x RMB180 billion non-GAAP net profit by FY25.

J&T Global Express Pre-IPO Tearsheet

By Clarence Chu

  • J&T Global Express (1936374D CH) is looking to raise about US$1bn in its upcoming Hong Kong IPO.
  • J&T Global Express (J&T) is a global logistics service provider. 
  • As per Frost & Sullivan (F&S), the firm is the leading express delivery business in Southeast Asia, with a 22.5% market share as per 2022 parcel volume.

J&T Global Express IPO: The Bull Case

By Arun George

  • J&T Global Express (1936374D CH), a leading express delivery business in Southeast Asia and China has filed for a HKEx IPO to raise US$1 billion, according to press reports.   
  • J&T is the number one express delivery operator in Southeast Asia by parcel volume from 2020 to 2022, according to Frost & Sullivan. 
  • The key elements of the bull case rest on large addressable markets, market share gains, robust reported revenue growth and narrowing losses which set a path to profitability.

Shiyue Daotian (十月稻田) Pre-IPO: Aggressive Brands – A Local Viewpoint

By Ming Lu

  • The company mainly sells its products online and spends much of its advertising budget online.
  • The rice market is fragmented and there are two main competitors, Arawana and Fortune.
  • We believe the company’s dry food can use the reputation of its rice to boost sales.

Morning Views Asia: Yankuang Energy Group

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Mobvoi IPO: Rapidly Growing AI Unicorn And Creator of Universal LLM “Xuliehouzi.”

By Andrei Zakharov

  • Mobvoi, the innovative Chinese AI company backed by Google, Volkswagen Group, and top-tier VC firms, filed for a Hong Kong IPO. The company plans to raise between $200M and $300M. 
  • Mobvoi is a rapidly growing AI unicorn. Revenue from AI software solutions skyrocketed 400%+ y/y in 2022. The company will launch AI painting assistant and AI writing assistant 2.0. soon.
  • China-Based startup chose CICC and CMB international to tap capital markets to develop universal LLM, market expansion, strategic alliances, acquisitions, and working capital. 

Viva Biotech Holdings (1873.HK) – The Restructuring Plan Would Not Turn Things Around

By Xinyao (Criss) Wang

  • In the past few years, the investment business and M&A of Viva accelerated based on a series of financing tools such as IPO/placement/convertible bonds. Thus, Viva’s scale has grown rapidly.
  • Continuous decline in stock price ultimately triggered a “redemption crisis” for Viva’s convertible bonds.Although Viva resolved it by transferring equity in its CRO subsidiary, the prospects are still not optimistic.
  • Due to the downturn in innovative drug industry and deterioration of financing environment,whether the high valuation of Viva’s CRO business would be recognized by secondary market is a question mark.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars